RIFM dermal absorption symposium
This article was originally published in The Rose Sheet
Executive Summary
The Research Institute for Fragrance Materials will hold a symposium "to provide information on [its] current understanding of the mechanics of skin absorption and present the experimental methods available to assess percutaneous penetration." Symposium will take place Nov. 13 at the American College of Toxicology's annual meeting in Charlotte, North Carolina. The absorption of compounds through the skin - whether incidental or by design - may be associated with toxicological hazards, RIFM notes, stressing that exposure quantification and risk assessment are needed to protect human health. Attendees of the symposium also will gain insight into the latest developments in mathematical/physiological dermal absorption modeling and take away a comparative analysis of available assessment methods using fragrance ingredients as an example. Those interested can register at 1www.actox.org...
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.